← FDA Drug Approvals (Drugs@FDA)

SYNERCID

NDA · New Drug Application · Sponsor: KING PHARMS · Approved 1999-09-21

Drug application

FDA Application #

NDA050748

Application type

New Drug Application

Brand name

SYNERCID

Generic name

Dalfopristin

Active ingredients

DALFOPRISTIN; QUINUPRISTIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

KING PHARMS

First approval

1999-09-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown